Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
  1. Home
  2. Search

Refine search

Refine search

Access:
Content type:
Publication date:
Apply   From and To filters
Subject: Show more
Journals Show more
Publishers: Show more
Societies Show more
Series: Show more
Collections: Show more

Actions for selected content:

Select all | Deselect all
  • View selected items
  • Export citations
  • Download PDF (zip)
  • Save to Kindle
  • Save to Dropbox
  • Save to Google Drive

Save Search

You can save your searches here and later view and run them again in "My saved searches".

Please provide a title, maximum of 40 characters.
Cancel
×

1 results

  • 4 - Access to Vaccine Technology

  • Ana Santos Rutschman, Villanova University, Pennsylvania
  • Book:
    Vaccines as Technology
    Published online:
    07 April 2022
    Print publication:
    14 April 2022, pp 93-105

  • Summary

    A vaccine that overcomes scientific, funding, and R&D constraints and enters the market may still not become available to everybody who needs it. The public health goal of preventing or lessening disease through the administration of vaccines is not fulfilled at the point of market entrance. Rather, it requires that populations indicated for a particular vaccine are able to receive it. A separate dimension of investigating how well the vaccine innovation ecosystem functions is thus the problem of access to existing vaccines.